Skip to content

NIH K08 Winners and Award History 2026

Grantsights·12 min read·Last updated October 2026

Quick Answer: NIH made 236 new K08 awards in FY2026, according to a Grantsights pull of NIH RePORTER on October 12, 2026, up from 196 in FY2025.

Get deadline alerts for these grants

Enter your email for a weekly email of upcoming grant deadlines.

No spam. A weekly email with upcoming grant deadlines.

This guide is for: Physician-scientists, veterinarian-scientists and other clinically trained researchers weighing a K08, along with their division chiefs and mentors, who want to see the real size and shape of the K08 winner pool before committing protected time to an application.

Last updated: October 12, 2026

Full answer: NIH made 236 new K08 awards in FY2026, according to a Grantsights pull of NIH RePORTER on October 12, 2026, up from 196 in FY2025. The median first-year award was $181,048 in total cost. Nearly half of new awards (47%) were A1 resubmissions, and California, Massachusetts and New York held 46% of them. NCI, NHLBI and NIAID funded the most. RePORTER lists funded projects, not applications, so none of this is a success rate.

FY2026 K08 signal (RePORTER pull, Oct 12, 2026)Value
New K08 awards (type 1, includes A1 resubmissions)236
All K08 records, new plus continuing years1,011
Median first-year total cost$181,048
Middle 80% of first-year total cost$158,511 to $284,310
Total first-year cost, new awards$47.5M
New awards that were A1 resubmissions110 (47%)
Institutions with a new K0880

NIH K08 Winners and Award History: FY2019 to FY2026 RePORTER Data

Data note: Grantsights pulled NIH RePORTER project search API records for activity code K08 in fiscal years 2019 through 2026 on October 12, 2026. New awards are project numbers starting with "1" (new applications and A1 resubmissions), deduplicated by application ID. Amounts are RePORTER's award_amount, the total cost (direct plus indirect) obligated for the fiscal year. Medians exclude a few records under $1,000 that look like adjustments. FY2026 ended September 30, 2026, and RePORTER had loaded K08 records through October 3, 2026.

According to NIH, the parent K08 notice for projects without an independent clinical trial (PA-24-182) gives clinically trained scientists 3 to 5 years of protected, mentored research time. Candidates must commit at least 75% of full-time professional effort, or 9 person-months, and hold a full-time appointment at award. The notice expires May 8, 2027.

Grantsights analysis of 8,466 K08 RePORTER records over eight fiscal years shows a mechanism that's stable in size and heavy on resubmissions. New awards have stayed between 196 and 242 a year. In five of the eight years, at least half of new awards were A1s. A K08 is usually a two-round effort, and departments that budget protected time for only one round are planning against the record.

How Many K08 Awards NIH Makes Each Year

According to NIH RePORTER, new K08 counts moved in a narrow band from FY2019 to FY2026.

Fiscal yearNew K08 awardsAll K08 recordsMedian first-year total costShare that were A1 resubmissions
2019242991$176,14843%
20202391,036$178,83540%
20212181,097$174,74950%
20222411,128$171,72055%
20231971,096$179,28053%
20242071,095$177,12063%
20251961,012$173,66455%
20262361,011$181,04847%

The median award hasn't kept pace with inflation. It was $176,148 in FY2019 and $181,048 in FY2026, a rise of under 3% over seven years. Most K08 money is salary, and institute salary limits have moved slowly, so the gap between what the K08 pays and what a clinician-scientist earns tends to widen. The candidate's department usually covers that difference, which is worth confirming in writing before you apply.

FY2026 awards arrived late in the year: 94 of 236 (40%) had August or September notice dates.

K08 Award Amounts in Detail

Specifically, the FY2026 median new K08 had $167,637 in direct cost and $181,048 in total cost. K08 indirect costs are limited to 8% of modified total direct costs.

MetricFY2024FY2025FY2026
New awards207196236
Median total cost$177,120$173,664$181,048
10th percentile$155,326$151,545$158,511
90th percentile$268,939$235,689$284,310
Highest single record$330,942$315,246$790,560
Total first-year cost$39.2M$35.7M$47.5M

Two FY2026 NIMH records, at Massachusetts General Hospital ($790,560) and Children's Hospital of Philadelphia ($721,440), are far above everything else. Amounts that large for a K08 look like more than one year funded at once. They aren't typical and shouldn't shape a budget.

The parent notice lets each institute set its own salary and research development limits. The research development money pays for supplies, equipment, technical staff, travel and coursework, but not mentor salary. Total federal salary can't exceed the NIH salary cap, which is $228,000 from January 1, 2026. Check the institute-specific table linked from the notice before you set the budget.

Where K08 Awards Go

According to NIH RePORTER, UCSF made the most new K08s in both FY2025 and FY2026.

RankInstitutionFY2026 new K08sFY2025FY2024
1University of California, San Francisco21174
2Stanford University1399
3University of Pennsylvania1156
4University of Michigan, Ann Arbor1056
5Sloan Kettering Institute for Cancer Research1013
6Massachusetts General Hospital91116
7Yale University937
8Children's Hospital of Philadelphia882
9Brigham and Women's Hospital879
10University of California, Los Angeles845
RankFY2026 stateNew K08sFY2025 stateNew K08sFY2024 stateNew K08s
1California54California38Massachusetts42
2Massachusetts31Massachusetts32New York28
3New York24Pennsylvania19California25
4Pennsylvania22New York14Pennsylvania13
5Michigan10Tennessee10North Carolina11
6Connecticut9Texas8Missouri11
7Missouri8Missouri8Ohio8

The K08 is a hospital-heavy award. Independent hospitals held 49 of the 236 FY2026 awards (21%) and schools of medicine 150 (64%). Children's hospitals and cancer centers appear often in the institution list because the K08 suits pediatric subspecialists and oncologists who run labs.

UCSF's jump from 4 new K08s in FY2024 to 21 in FY2026 is the biggest single-institution change. Sloan Kettering went from 1 to 10 in a year. Small numbers make one institution's count swing, so use these as signs of a strong local pipeline, not as stable rankings.

Which Institutes Fund K08s

Nineteen institutes made new K08 awards in FY2026. NCI and NHLBI traded the top spot across the three years.

RankFY2026New K08sFY2025New K08sFY2024New K08s
1NCI49NHLBI49NCI49
2NHLBI42NIAID33NHLBI38
3NIAID34NIDDK21NIAID26
4NIDDK25NCI20NIDDK23
5NINDS17NINDS18NINDS14
6NIAMS14NIAMS14NIAMS9
7NIMH9NEI, NIDCR, NIMH, NICHD, NIA5 eachAHRQ8

NCI's dip to 20 in FY2025 and recovery to 49 in FY2026 is the sharpest move. It's consistent with FY2025 award delays rolling into FY2026, though RePORTER can't confirm that. Across all three years, the top four institutes (NCI, NHLBI, NIAID and NIDDK) made more than half of new K08s. A candidate whose work fits a smaller institute should call that institute's career-development program officer early, because a handful of awards a year leaves little room.

FY2026 funding noticeNew K08 awards
PA-24-182, independent clinical trial not allowed224
PA-24-181, independent clinical trial required8
Other K08 notices4

K08 Eligibility, Effort and Due Dates

RuleCurrent requirementSource
DegreeClinical doctorate (MD, DO, DDS, DMD, OD, DC, PharmD, ND, DVM) or a PhD in a clinical disciplinePA-24-182
CitizenshipUS citizen, non-citizen national, or permanent resident by awardPA-24-182
Prior awards that disqualifyCurrent or former PI of R01, P01, P50, DP5, K01, K07, K08, K22, K23, K25, K76, K99/R00PA-24-182
Prior awards that don'tR03, R21/R33, R34, R36, SBIR/STTR, K12 or KL2 scholarsPA-24-182
EffortAt least 75% (9 person-months)PA-24-182
Project period3 to 5 yearsPA-24-182
Trial-led projectsUse PA-24-181PA-24-181

NIH's standard due dates put K-series new applications on February 12, June 12 and October 12, with resubmissions a month later. A weekend or federal holiday moves the date to the next business day.

ApplicationNext dateThen
NewTuesday, October 13, 2026 (moved from the October 12 holiday)Friday, February 12, 2027
ResubmissionThursday, November 12, 2026Friday, March 12, 2027

Pain researchers should know that NIH ended the HEAL PainCare clinician K08/K23 program early in January 2026 (NOT-NS-26-030). The parent K08 is still open to pain topics through a participating institute.

What NIH RePORTER Doesn't Tell You About K08 Winners

RePORTER shows the 236 awards. It doesn't show how many K08 applications NIH received, so it can't produce a success rate. The NIH K-award success rates by institute page covers those published rates.

RePORTER showsRePORTER leaves out
Candidate, institution, institute, dollarsClinical specialty and how much clinical time the candidate gave up
Whether the award was a resubmissionThe first-round score and what changed
Project abstractThe mentor team and the department's commitment letter
Notice dateWhether the candidate later won an R01

The 75% effort rule is where many K08 plans fail. A surgeon or interventional specialist has to cut clinical work to a quarter of full time for 3 to 5 years, and the department has to agree in writing. Reviewers read the chair's letter closely. A vague promise of "protected time" is a red flag.

Grantsights checked the notice split in RePORTER against the two parent notices: 224 of 236 FY2026 awards came through the no-trial notice, so the trial-required K08 is a small door. If your project would make you the lead on a clinical trial, compare the K23 before forcing it into a K08.

Is the K08 Worth 3 to 5 Years of Reduced Clinical Work?

At a $181,048 median first-year award, the K08 rarely covers a clinician-scientist's full salary at 75% effort, especially in procedural specialties. The money isn't the point. The award buys guaranteed research time during the years when clinical pressure is highest, and a funded K is one of the strongest signals a department can show when it protects a junior faculty member's lab.

The K08 is worth it when three things are true: the department will cover the salary gap, the mentor has trained K awardees before, and the candidate has a research direction that can produce R01-level preliminary data within the award period. If any one of those is missing, the honest answer is to wait. A K08 awarded to a candidate who then can't protect the time tends to end without an R01, and the eligibility rules bar former K08 PIs from the other mentored K awards listed in the notice, so there's no second try at a mentored K.

For clinicians who already have independent preliminary data and strong lab support, an R21 or R01 may be the better route. The K08 eligibility rules allow R03 and R21 holders to apply, so an R21 first doesn't close the door. Run the numbers on both paths with your division chief: protected time, salary support, and how many cycles each route is likely to take, given that about half of recent K08 winners needed an A1.

Should You Apply for a K08 Now?

Your situationBest route
Clinician running lab or translational research with a committed mentorApply to PA-24-182
Patient-oriented researchCompare the K23 first
You'd lead a clinical trialPA-24-181, or a trial-required K23
You already hold an R01 or another KSkip; you're not eligible
Your department can't guarantee 75% effortWait until it can

Apply with a plan for two rounds. The data says most winners need one. Use the first summary statement to fix the career development plan as much as the science.

Read the NIH K23 award history to see how the patient-oriented track compares, and the NIH K01 award history for the non-clinical counterpart. For the jump after a K08, the NIH R01 award history shows what the next award looks like. The NIH R01, R21, R03 and K awards comparison sets out the differences side by side. To search other open NIH funding, use the free Grantsights NIH grant search.

To run your own check, open the NIH RePORTER project search, filter to activity code K08 and your target institute, and read the abstracts of the last three years of awards in your specialty.

Sources

More award history and success-rate data

Who won, how many awards were made, and success rates, from public award records and agency tables.

NIH

USDA NIFA

SBIR

G

Published by

Grantsights

Grantsights editorial content is reviewed against current program pages, award lists, notices, regulations, and application guidance before publication.

Source review

Each guide names the primary sources used for its program. Status, deadlines, eligibility, application routes, and award figures are checked against the source that owns that fact before publication. The page identifies its review date and separates current rules from historical planning evidence.

  • Primary sources selected from the agency, notice, regulation, or award system that owns each claim
  • Status, deadline, eligibility, and award figures rechecked at the page's displayed source-review date

Editorial accountability

Erik Jia, Founder and Editorial Lead

Accountable for source standards, corrections, product claims, and data-source transparency.

Source trust

How this guide is reviewed

Grant guides are checked against official sources, reviewer lanes, source dates, and correction rules before they feed users into grant pages.

Frequently Asked Questions

How many NIH K08 awards were made in FY2026?

NIH RePORTER showed 236 new K08 awards for FY2026 when Grantsights pulled it on October 12, 2026, up from 196 in FY2025 and 207 in FY2024. Annual counts have stayed between 196 and 242 since FY2019.

How much is a K08 award?

The median FY2026 new K08 record carried $181,048 in total cost for its first year, including 8% indirect costs. The middle 80% ran from $158,511 to $284,310. Salary limits are set by each institute, within the NIH salary cap.

Do most K08 winners resubmit?

About half do. A1 resubmissions made up 47% of new FY2026 K08 awards, 55% in FY2025, and 63% in FY2024, according to the Grantsights RePORTER pull.

Who is eligible for a K08?

Candidates need a clinical doctoral degree such as an MD, DO, DDS or DVM, or a PhD in a clinical discipline, plus US citizenship or permanent residency by award. Current or former PIs of an R01, K01, K23, K99/R00 and several other awards aren't eligible, but R03 and R21 PIs are.

When is the next K08 due date?

October 12 is a federal holiday in 2026, so the new-application date moves to Tuesday, October 13, 2026. The next new date after that is February 12, 2027. Resubmissions are due November 12, 2026 and March 12, 2027.

What is the difference between a K08 and a K23?

Both serve clinician-scientists. The K08 covers laboratory, translational and other research that isn't patient-oriented, while the K23 is for patient-oriented research. Candidates who'd lead a clinical trial need the K08 trial-required notice (PA-24-181) or the K23.

Last updated: October 12, 2026. This page is reviewed regularly and updated when eligibility requirements, deadlines, or funding amounts change.

Get deadline alerts for grants like these

Enter your email for a weekly email of upcoming grant deadlines. When this guide has a current verified report, the confirmation email links to its free sample. Available reports are $49 each.

No spam. A weekly email with upcoming grant deadlines.